Theranostics is moving beyond oncology — and IMV’s latest PET Census data shows exactly where adoption is shifting. Download the free snapshot pdf.

In vivo CAR-T is moving from concept to clinic and it’s redistributing analytical instrument demand in ways OEMs can’t afford to miss. SDi maps where the opportunity is shifting.

For more than a decade, CAR-T cell therapy has represented one of medicine’s most exciting frontiers, a technology capable of sending certain blood cancers into lasting remission after all other treatments have failed. Yet for…

443 life science researchers across North America, Europe, and APAC share their unfiltered views on AI adoption, trust, and unmet needs in the lab. Get the report sample.

Radiopharmaceuticals are experiencing a renaissance. From precision oncology with lutetium-177-based therapies to increasing demand for diagnostic procedures performed daily in the U.S., nuclear medicine has never been more clinically vital. However, beneath this wave of…